AI Article Synopsis
- A woman in her mid-twenties developed a headache and was eventually diagnosed with cerebral venous sinus thrombosis 10 days after getting her first dose of the AstraZeneca vaccine.
- The case highlights a potential serious side effect related to the ChAdOx1 nCoV-19 vaccine.
- The report includes findings from clinical investigations and raises important questions about the safety of this vaccine.
Article Abstract
A woman in her mid-twenties was admitted with headache, ultimately leading to a diagnosis of cerebral venous sinus thrombosis 10 days after receiving a first dose of the AstraZeneca ChAdOx1 nCoV-19 vaccine (Vaxzevria). We report this case from clinical investigations to outcomes and discuss the issues raised by it regarding the ChAdOx1 nCoV-19 vaccine.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107960 | PMC |
| http://dx.doi.org/10.1177/20480040231169464 | DOI Listing |
Publication Analysis
Top Keywords
chadox1 ncov-19
12
ncov-19 vaccine
8
ncov-19 astrazeneca
4
astrazeneca covid-19
4
covid-19 vaccine
4
vaccine woman
4
woman mid-twenties
4
mid-twenties admitted
4
admitted headache
4
headache ultimately
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!